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Enhanced Psychosocial Well-Being Following Participation
in a Mindfulness-Based Stress Reduction Program
Is Associated with Increased Natural Killer Cell Activity
Carolyn Y. Fang, Ph.D.,1 Diane K. Reibel, Ph.D.,2 Margaret L. Longacre, Ph.D.,1 Steven Rosenzweig, M.D.,3
Donald E. Campbell, Ph.D.,4 and Steven D. Douglas, M.D.4
Abstract
Background: Mindfulness-based stress reduction (MBSR) programs have consistently been shown to enhance
the psychosocial well-being of participants. Given the well-established association between psychosocial factors
and immunologic functioning, it has been hypothesized that enhanced psychosocial well-being among MBSR
participants would be associated with corresponding changes in markers of immune activity.
Objectives: The objectives of this study were to examine changes in psychosocial and immunologic measures in
a heterogeneous patient sample following participation in a MBSR program.
Design: A single-group, pretest=post-test design was utilized.
Setting: The intervention was conducted at an academic health center.
Subjects: This pilot study involved 24 participants (aged 28–72 years). Inclusion criteria were as follows: 18
years of age, English-speaking, and no known autoimmune disorder.
Intervention: The intervention was an 8-week MBSR program.
Outcome measures: Distress and quality of life (QOL) measures included the Brief Symptom Inventory-18 and
the Medical Outcomes Survey Short-Form Health Survey, respectively. Immunologic measures included natural
killer (NK) cell cytolytic activity and C-reactive protein (CRP).
Results: Patients completed psychosocial assessments and provided a blood sample at baseline (pre-MBSR) and
within 2 weeks post-MBSR. Significant improvements in anxiety and overall distress as well as across multiple
domains of QOL were observed from baseline to post-MBSR. Reductions in anxiety and overall distress were
associated with reductions in CRP. Patients who reported improvement in overall mental well-being also
showed increased NK cytolytic activity from pre- to post-MBSR, whereas patients who reported no improve-
ment in mental well-being showed no change in NK cytolytic activity.
Conclusions: Positive improvement in psychologic well-being following MBSR was associated with increased
NK cytolytic activity and decreased levels of CRP.
Introduction
The intimate connection between mind and body hasgradually become more broadly accepted in Western
medicine over the past few decades. Today, it is no longer
considered radical for a patient to incorporate a mind–
body intervention into a treatment plan to complement
‘‘traditional’’ medical approaches for healing. This shift in
medical mindset was highly influenced by the work of Jon
Kabat-Zinn and colleagues, and the mindfulness-based stress
reduction (MBSR) program in particular.
MBSR is an 8-week standardized program that teaches
participants mindfulness practice, or the act of being in the
moment. Through mindfulness practice, participants come to
identify automatic reactions and reflexive thoughts occurring
in response to external and internal events. Empirical data
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indicate that MBSR participants experience enhanced psy-
chosocial and physical functioning.1–4
Specific psychosocial improvements include improved
quality of life and reductions in psychologic distress.4,5 In-
deed, meta-analyses of MBSR studies concluded that MBSR
is associated with robust effects on psychosocial well-being
across studies of patients with a wide range of health con-
ditions and disorders.1,6 For example, it has been demon-
strated that mindfulness training can be helpful in reducing
the stress that accompanies cancer diagnosis and treatment.7
Given that stress is associated with immune dysregula-
tion,8 it has been proposed that participation in MBSR can
lead to not only decreased stress,1 but also enhanced im-
mune functioning. Findings from a variety of studies provide
evidence for the existence of a stress-immunity pathway.9–13
Psychologic stress may lead to changes in immune func-
tioning via two pathways: (1) through the central nervous
system with the activation of the sympathetic nervous sys-
tem; or (2) through neuroendocrine-immune pathways (i.e.,
the release of hormones).14 Indeed, a number of studies have
shown that psychologic responses to stressful events can
produce immunologic changes in both healthy and patient
populations.15–17 For example, significant declines in natural
killer (NK) cell numbers and activity have been observed
during periods of high stress (e.g., marital conflict18,19).
Stress-related alterations in immune functioning have also
been observed among patients undergoing diagnosis of,20
and treatment for,21 cancer. Among breast cancer patients
undergoing surgical treatment, self-reported levels of stress
were associated with immune downregulation, including
reduced NK cell cytotoxicity, even after controlling for po-
tential confounding variables such as patient age and disease
stage.21 Therefore, based on the body of work demonstrating
a stress-immune pathway, interruption of the stress-response
(through mindfulness practice) could potentially have
physiologic implications for immune functioning. Guided by
a psychoneuroimmunologic framework that proposes that
psychosocial factors may influence immunologic outcomes
via sympathetic nervous system and neuroendocrine path-
ways,22 it is proposed that changes in psychologic well-being
are likely to be associated with corresponding changes in
immunologic functioning.
At present, few studies have directly examined the asso-
ciation between change in psychosocial well-being and im-
mune parameters following MBSR. Several studies have
reported improved immune functioning among MBSR
participants, but these same studies either showed no asso-
ciation between immune functioning and psychosocial
well-being post-MBSR7,23 or failed to assess this relation-
ship.24 For example, significant improvements in quality of
life and stress symptoms as well as a general shift away from
a proinflammatory (or Th1) response to an anti-inflamma-
tory (Th2) type response were identified among breast and
prostate cancer patients following participation in MBSR.7,25
Moreover, significant increases in immunologic functioning
(i.e., NK cell activity) were also reported among HIVþ
patients following participation in MBSR.23 An association
between immune functioning and psychosocial well-being
was not identified in either study. Furthermore, recent
research by Witek-Janusek and colleagues24 showed a re-
establishment of NK cell activity and cytokine production
levels over time as well as reductions in cortisol levels among
75 early-stage breast cancer patients participating in MBSR
compared to non-MBSR controls. However, the relationship
between immune functioning and psychosocial well-being
was not assessed.
Thus, we conducted a pilot study to examine whether
improvement in psychosocial well-being is associated with
enhanced immune functioning among a heterogeneous pa-
tient population participating in a MBSR program. Specifi-
cally, it was hypothesized that immunologic changes would
most likely be observed among the MBSR participants who
showed improvement in psychosocial functioning.
Materials and Methods
Participants and procedures
A single-group, pretest=post-test design was utilized. Eli-
gible participants were individuals enrolled in an 8-week
MBSR program at a university medical center. Eligibility
criteria were as follows: 18 years of age or older, English
speaking, and able to provide informed consent. Because the
primary outcome involved immunologic measures, we ex-
cluded individuals with significant immune dysregulation,
including known diagnosis of an autoimmune disorder,
HIV-positive status, and use of systemic steroid medication
within the previous 3 months.
In this pilot study, 53 individuals were approached about
participating in the study. Of the 53 who were contacted, 13
individuals (24.5%) were ineligible and 12 individuals
(22.6%) declined to participate, leaving 28 individuals
(52.8%) who were interested in participating. Of the 28 in-
dividuals, 24 individuals (45.3%) were consented and com-
pleted study assessments prior to the first MBSR session.
Written informed consent was obtained prior to the
baseline assessment. At baseline, participants completed the
psychosocial questionnaires and provided a blood sample
(20 mL) for immunologic assays. Blood samples were drawn
in the evening between 5:30 pm and 9:30 pm. Post-test as-
sessments were obtained within 2 weeks following the final
MBSR session. At post-test, participants completed the psy-
chosocial questionnaires and provided another blood sam-
ple. During the 8-week program, 5 participants (1 male, 4
females) did not complete the MBSR program, and we were
not successful in obtaining follow-up data from those 5 who
dropped out. Reasons for dropping out included not being
able to complete the 8-week program due to medical reasons
(n¼ 2); the program was not as expected (n¼ 1); and the
need to reschedule due to personal schedule change (n¼ 1).
One participant failed to attend the last three classes and
provided no explanation for dropping out of the program.
Finally, 1 participant completed 7 of the 8 weeks, but missed
the final class due to illness. Due to an extended illness, we
were unable to obtain a blood sample from this participant
within the 2-week post-MBSR period. Participants did not
differ from noncompleters on age or baseline psychosocial
and immunologic measures. Therefore, baseline data from
the 6 participants who did not complete the program were
excluded from the analyses.
Intervention
The 8-week MBSR program, modeled after the program
created by Jon Kabat-Zinn,26 is a standardized, group-based
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intervention. Each class was 2.5 hours in length and partic-
ipants were asked to practice 20–30 minutes of meditation a
day at home, 6 days a week.
Measures
Psychosocial functioning and quality of life. Psychosocial
distress was measured using the Brief Symptom Inventory-
18 (BSI-18).27 The BSI-18 is highly reliable and valid, yielding
three subscale scores: somatization, depression, and anxiety.
Internal consistency of each subscale ranges from 0.74 to
0.90. The composite score, the General Severity Index, also
demonstrates high levels of reliability and internal consis-
tency. Quality of life (QOL) was measured using the Medical
Outcomes Survey Short-Form Health Survey (SF-36),28
which assesses eight domains of health-related QOL: physi-
cal functioning, role limitations due to physical problems,
bodily pain, general health, vitality, social functioning, role
limitations due to emotional problems, and mental health. In
addition, two component scale values were computed to
summarize physical well-being (Physical Components Score)
and mental well-being (Mental Components Score, MCS).
The SF-36 is widely used in studies of patient populations.29
Immunologic measures. Due to the heterogeneous na-
ture of the patient sample, we chose to assess general
markers of systemic immune function including natural
killer cell cytolytic activity and high-resolution C-reactive
protein (CRP). These particular measures were chosen to
characterize two components of immunocompetence: non-
specific cell-mediated cytotoxicity (NK cell cytotoxicity) and
inflammation (CRP). Of the acute-phase proteins, CRP is of
particular interest because it mimics the action of antibodies,
but unlike antibodies, this protein has broad specificity for
pathogen molecules. CRP is also the most commonly used,
acute-phase reactant marker of inflammation in the body. The
presence of a systemic inflammatory response (as indicated by
increased circulating levels of CRP) has been shown to predict
risk of recurrent coronary events after myocardial infarc-
tion,30,31 diabetes risk,32 and survival in patients with can-
cer.33,34 Levels of CRP were assessed on frozen samples using
a high-sensitivity, two-site enzyme-linked immunoassay.
NK cells serve as an early defense against certain intra-
cellular infections and are able to recognize and kill a limited
range of abnormal cells. NK cells are important in innate
immunity and serve as an early defense against certain
intracellular infections. NK cells serve as the effectors in
antibody-dependent cell-mediated cytotoxicity (i.e., the de-
struction of antibody-coated target cells) and have the ability
to kill certain lymphoid tumor cell lines in vitro without the
need for prior immunization or activation. NK cells bear no
known antigen-specific receptors, but are able to recognize
and kill a limited range of abnormal cells.
The functional capability of NK cells can be determined by
exposing them to a known NK-specific target that is radio-
actively labeled. NK cell activity is quantified in this assay by
using the K562 cell line, which is known to be NK sensitive.
Aliquots of 100 mL of various concentrations of peripheral
blood mononuclear cells (PBMC effector cells) were incu-
bated in triplicate with 100 mL of labeled target cells for
4 hours at 378C with 5% CO2 (effector-to-target ratios of 50:1,
25:1, 12.5:1, and 6.25:1 were studied). Maximum release of
51Cr was determined by addition of 100 mL of 1% Triton X
solution to triplicate wells of K562 cells. At the end of the
incubation period, 100-mL aliquots of the supernatants were
harvested and counted in a g counter (Beckman Instruments,
Fullerton, CA). NK activity was calculated as [(mean sam-
ple activity – mean spontaneous release)=(mean maximum
release – mean spontaneous release)]100. The results were
expressed as percent cytotoxicity.
Lytic units (LU) per 107 PBMCs and LU per 107 NK cells
were calculated according to the method of Bryant et al.35
NK functional assays do not discriminate between cytotox-
icity mediated by a few highly active NK cells versus many
NK cells in any one particular sample of PBMCs. Therefore,
expressing data as LU per NK cell adjusts for the differences
in the percentage of NK cells (CD3-CD16þCD56þ) in the
effector cell population PBMCs.36 NK cell numbers in the
effector cell population were determined by automated flow
cytometry at the time of the NK cell assay.37 The functional
data are expressed both as LU per PBMC (LU20 PBMC) and
LU per NK cell (LU20 NK).
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Statistical analysis
Data were analyzed using SPSS Version 16.0. Changes in
psychosocial and immunologic functioning from pre- to
post-MBSR were analyzed using paired samples t tests.
Correlation analyses between change scores on psychosocial
and immune measures were examined to assess if, as hy-
pothesized, immunologic changes would most likely be ob-
served in those individuals who showed the greatest change
in psychosocial functioning. Residualized change scores used
in the correlational analyses were calculated using the pro-
cedure described by Cohen and Cohen.39 Another way to
examine whether change in psychosocial functioning was
associated with change in immunologic measures that takes
into account baseline values is to conduct regression analyses
using the post-MBSR immune variables as the dependent
variable, and the pre-MBSR (baseline) immune values and
change in psychosocial functioning as the predictor vari-
ables. Finally, we divided the sample into two subgroups:
Those who reported any positive increase in mental well-
being (MCS) from pre- to postintervention and those who
reported no change in mental well-being. A 2 (group: posi-
tive change versus no change) 2 (time) repeated-measures
analysis of variance (ANOVA) was used to examine change
in measures of CRP and NK cytolytic activity (LU20 NK and
LU20 PBMC) from pre- to post-MBSR by group.
Results
Demographic findings
Participants included 12 female and 6 male participants.
Diagnoses included chronic pain (44%), symptoms of anxiety
and depression (39%), hypertension (11%), and cancer (6%).
The mean age of the participants was 50.82 years (standard
deviation (SD)¼ 14.06, range¼ 28–72). In preliminary ana-
lyses, we observed that 1 male participant had outlier results
on NK cytolytic activity (ranking higher than 2 SD above the
mean), and therefore, we did not include data from that
participant in any subsequent analyses. Additional prelimi-
nary analyses revealed no associations between participant
age and any of the immune measures.
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Psychosocial and immunologic measures
from pre- to post-MBSR
Psychosocial well-being. Significant decreases in anxiety
(t¼ 3.40, p< 0.01) and overall distress (i.e., BSI General Se-
verity Index) (t¼ 2.55, p< 0.05) were observed from pre- to
post-MBSR (Table 1). Significant improvements were also
identified on both the QOL Physical Composite Score
(t¼2.41, p< 0.05) and the Mental Composite Score
(t¼2.26, p< 0.05), as well as across multiple aspects of
QOL, including role limitations due to physical problems
(t¼2.67, p< 0.05), social functioning (t¼2.24, p< 0.05),
vitality (t¼2.43, p< 0.05), general health (t¼3.51,
p< 0.01), and mental health (t¼2.82, p¼ .01).
Immunologic functioning. No significant change in CRP
levels and percentage or absolute NK cells was detected from
baseline to post-MBSR. LU20 NK and LU20 PBMC increased
from baseline to post-MBSR, although these changes did not
reach statistical significance at the two-tailed level. Pre- and
post-MBSR assessments of immunologic measures are pre-
sented in Table 1.
Associations between psychosocial
and immunologic functioning
Correlational analyses between changes in psychosocial
and immunologic functioning. Improvements in the Mental
Component Summary (MCS) score were correlated with
increased LU20 NK and LU20 PBMC (rs¼ 0.59 and 0.63, re-
spectively, ps< 0.02). Enhanced mental health was also sig-
nificantly correlated with increases in LU20 NK and LU20
PBMC (rs¼ 0.69 and 0.71, respectively, ps< 0.01). Improve-
ment in general health was positively correlated with in-
creased LU20 PBMC (r¼ 0.54, p< 0.05). Reductions in anxiety
and overall distress were significantly correlated with re-
ductions in CRP (rs¼ 0.64 and 0.52, respectively; ps< 0.05).
Regression analyses. An alternative analytic approach
for evaluating the relationship between changes in psycho-
social and immunologic functioning while adjusting for
baseline values of the biological variables is to use linear
regression and include the baseline immune measure as a
covariate. Results from regression analyses provided a sim-
ilar account of findings. Specifically, a positive change (im-
provement) in mental health was positively associated with
LU20 NK (b¼ 0.43, t¼ 3.25, p< 0.01) and LU20 PBMC
(b¼ 0.50, t¼ 2.83, p¼ 0.013). Similarly, improvements in the
Mental Component Summary (MCS) score were positively
associated with post-MBSR LU20 NK (b¼ 0.35, t¼ 2.23,
p¼ 0.04), controlling for baseline values. Improvements in
general health were also positively associated with post-
MBSR LU20 PBMC (b¼ 0.33, t¼ 2.14, p¼ 0.05), controlling
for baseline values.
Regression analyses also indicated that reductions in de-
pression, anxiety, and overall distress were significantly as-
sociated with lower post-MBSR CRP levels, controlling for
baseline CRP levels. Specifically, a decrease in depression
was associated with lower post-MBSR CRP levels (b¼ 0.17,
t¼ 2.25, p¼ 0.04). Similarly, decreases in anxiety and overall
distress were also associated with lower post-MBSR CRP
levels (b¼ 0.20, t¼ 2.77, p< 0.02 for anxiety; b¼ 0.17, t¼ 2.25,
p¼ 0.04 for overall distress).
Changes in immunologic functioning among patients
with improved psychosocial functioning. Participants who
reported any positive increase on the MCS from pre- to post-
MBSR assessment were categorized as showing ‘‘improve-
ment’’ in their psychosocial well-being. Of the participants
Table 1. Psychosocial and Immunologic Measures at Pre- and Post–Mindfulness-Based
Stress Reduction (MBSR) Assessments
Measure Pre-MBSR mean (SD) Post-MBSR mean (SD) t-Test (p-value)
Psychosocial functioning
Anxiety 6.60 (3.60) 3.65 (4.01) 3.40 ( p¼ 0.004)
Depression 6.87 (5.54) 4.80 (4.11) 1.62 ( p¼ 0.127)
Somatization 4.93 (4.95) 4.20 (5.05) 1.52 ( p¼ 0.151)
General Severity Index 18.40 (10.98) 13.07 (11.47) 2.55 ( p¼ 0.023)
Qualify of life
Physical functioning 67.07 (33.39) 73.06 (27.55) 1.67 ( p¼ 0.115)
Role–physical 30.88 (37.01) 57.35 (42.17) 2.67 ( p¼ 0.017)
Bodily pain 51.13 (32.38) 59.13 (27.61) 1.70 ( p¼ 0.109)
General health 55.38 (26.53) 67.19 (22.60) 3.51 ( p¼ 0.003)
Vitality 39.38 (21.12) 52.81 (16.83) 2.43 ( p¼ 0.028)
Social functioning 52.34 (31.36) 64.84 (22.92) 2.24 ( p¼ 0.041)
Role–emotional 45.10 (40.72) 62.75 (38.88) 1.77 ( p¼ 0.95)
Mental health 56.50 (16.58) 70.13 (13.22) 2.82 ( p¼ 0.013)
Physical composite score 39.97 (13.91) 44.02 (12.46) 2.41 ( p¼ 0.029)
Mental composite score 38.83 (11.68) 45.67 (9.95) 2.26 ( p¼ 0.039)
Immunologic variables
C-reactive protein (mg=L) 5.22 (8.29) 5.88 (9.29) 0.88 ( p¼ 0.39)
% NK cells 14.41 (5.16) 13.00 (4.33) 1.12 ( p¼ 0.28)
# NK cells=mL 268.29 (134.28) 289.18 (111.31) 0.70 ( p¼ 0.49)
NK activity (LU=107 NK cells) – LU20 NK 320.98 (286.50) 505.44 (474.06) 1.89 ( p¼ 0.078)
NK activity (LU=107 PBMCs) – LU20 PBMC 46.95 (47.23) 69.40 (73.39) 1.75 ( p¼ 0.098)
SD, standard deviation; NK, natural killer; LU, lytic units; PBMC, peripheral blood mononuclear cells.
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who were categorized as showing ‘‘improvement,’’ the mean
increase in MCS scores was 14.46 (SD¼ 10.36), and the range
was 4.72–34.71. Participants whose scores remained the same
or decreased from pre- to post-MBSR were categorized as
showing ‘‘no improvement’’ in their psychosocial well-being.
Of the participants who were categorized as showing ‘‘no
improvement,’’ the mean change in MCS scores was 4.10
(SD¼ 4.56), and the range was 0.58 to 12.79.
A repeated-measures ANOVA indicated no effects of
group (improved versus no improvement) or time (pre- to
post-MBSR) for CRP levels, percentage of NK cells, and ab-
solute NK cells. However, a significant grouptime inter-
action was observed for LU20 PBMC, F(1,16)¼ 5.29, p¼ 0.036.
Specifically, significant increases in LU20 PBMC from pre-
MBSR (M¼ 25.76, SD¼ 13.70) to post-MBSR (M¼ 93.20,
SD¼ 82.21) were observed among individuals who reported
positive improvement on the MCS score. In contrast, no
significant change in NK activity was observed among in-
dividuals who reported no improvement in MCS from pre-
MBSR (M¼ 38.70, SD¼ 38.01) to post-MBSR (M¼ 51.45,
SD¼ 52.75) (Fig. 1). Individual response data are also pre-
sented in a scatterplot (Fig. 2). A similar pattern of results
was observed for LU20 NK, where significant increases were
observed from pre-MBSR (M¼ 272.88, SD¼ 203.02) to post-
MBSR (M¼ 632.28, SD¼ 537.42) among individuals who
reported positive improvement on the MCS, but not among
those individuals who did not show improvement from pre-
MBSR (M¼ 338.12, SD¼ 381.97) to post-MBSR (M¼ 311.63,
SD¼ 241.07), F(1,16)¼ 4.29, p¼ 0.056.
Discussion
Knowledge regarding the intricate relationship between
mind and body will continue to advance in the coming years.
This broadening understanding will be fueled, in part, by
incorporating the assessment of markers of biological func-
tioning within studies of established mind–body interven-
tions, such as MBSR.4 Given the abundance of empirical data
demonstrating that psychosocial well-being is associated
with markers of immune functioning, this research sought to
expand the MBSR-related literature by assessing whether
changes in psychosocial well-being following MBSR partici-
pation are associated with corresponding changes in im-
mune functioning.
In the present study, psychosocial functioning of the
participants improved from pre- to post MBSR, including
significant decreases in anxiety and overall distress as well
as significant improvements across various aspects of QOL.
This is consistent with data from a number of prior studies
that have demonstrated beneficial effects of MBSR on psy-
chosocial functioning.1,6 In addition, changes in psychoso-
cial well-being were associated with related changes in
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immune parameters, including levels of CRP and NK
cytolytic activity.
Specifically, reductions in anxiety and overall distress
were significantly correlated with reductions in CRP. This
association is consistent with prior findings that have re-
ported that (1) higher levels of anxiety are associated with
higher levels of CRP40; (2) participation in MBSR leads to
reductions in anxiety and psychologic distress6; and (3)
participation in MBSR was observed to lead to a shift away
from a proinflammatory response among patients with
cancer.7 Moreover, the observed association between psy-
chosocial functioning and CRP is also consistent with prior
studies that have reported well-established relationships
between psychosocial distress and other pro-inflammatory
markers, such as interleukin-6.41,42
Previous studies also indicate that psychologic distress is
associated with reduced NK functional activity,24 whereas
improvements in psychologic functioning have been associ-
ated with increased NK functional activity.43,44 The present
finding that improvement in psychologic functioning was
associated with enhanced NK cytolytic activity is consistent
with prior studies and suggests possible directions for future
studies. For example, given that psychosocial distress can not
only influence NK cell function but also the trafficking of NK
cells into and out of peripheral circulation,45,46 future studies
may be designed to specifically examine whether partici-
pation in MBSR is associated with alterations in NK cell
trafficking and=or the pattern of leukocyte redistribution
between the blood and other immune compartments. In
addition, future studies may also investigate whether alter-
ations in innate cellular immunity are reversible with im-
provement in psychologic functioning following MBSR.
Finally, given the beneficial effects of MBSR on physiologic
outcomes in various patient populations (e.g., adults at high
risk for cardiovascular disease, individuals with diabetes),
future studies may propose to examine the hypothesis that
participation in MBSR leads to changes in immunologic
markers (e.g., reduced inflammation) that are directly rele-
vant to specific disease processes and outcomes (e.g., heart
disease).
We acknowledge several limitations of the present study.
First, given the pre–post study design, changes in immuno-
logic or psychosocial measures cannot be attributed with
certainty to participation in the MBSR program, as there was
no comparison group. It is possible that these changes would
have occurred naturally, due to external environmental fac-
tors or other reasons. Second, due to the heterogeneous na-
ture of the patient sample, we utilized nonspecific measures
of immunologic functioning. The clinical implications of
the observed changes in immunologic measures are not
well-defined. However, it is notable that despite the het-
erogeneity of the sample, meaningful associations were
detected between psychosocial well-being and immune
functioning. Third, the present study involved a relatively
small sample, and thus, power was limited for detecting
statistically significant changes. Fourth, we acknowledge
that a meaningful proportion of participants did not com-
plete the final assessment for various reasons. However, the
primary purpose of this pilot study was to examine whether
changes in psychosocial functioning were associated with
changes in immune functioning, and therefore, our focus
was necessarily on those participants among whom change
in functioning could be determined (i.e., provided pre- and
post-assessments). Finally, it is acknowledged that the as-
sociation between psychosocial well-being and immune
functioning could be attributed to other potential con-
founding factors that were not assessed in the present study,
such as sleep quality, changes in existing disease or symp-
toms, or psychologic comorbidities. In light of prior studies
that have reported beneficial effects of MBSR on sleep
quality and symptoms,47 future studies may propose to in-
vestigate whether the observed association between psy-
chosocial well-being and assessments of immune functioning
is mediated by, or can be attributed to, improvement in these
various other factors.
Conclusions
Data from this pilot study suggest that changes in psy-
chologic well-being following MBSR are associated with
changes in immune functioning. Future studies to evaluate
the hypothesis that enhanced psychosocial functioning leads
to corresponding immunologic changes should be conducted
using a randomized, controlled design.
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